News

Viewing Page 1 of 1 | Showing Results 1 - 2 of 2

New immunotherapy studies for people with advanced melanoma

July 24, 2017

Two new studies of investigational and FDA-approved immunotherapies for advanced melanoma are opening soon at Providence Cancer Institute.

Genomics studies aim to improve targeted therapies

June 27, 2017

Two studies at Providence Cancer Institute are focusing on patients’ genomes to help identify the most effective targeted anti-cancer therapies.

Viewing Page 1 of 1 | Showing Results 1 - 2 of 2